Skip to content
Search

Latest Stories

Stock shortage alert: Guanfacine ADHD medication unavailable until May

Stock shortage alert: Guanfacine ADHD medication unavailable until May

While alternative ADHD medications remain accessible according CPE, they "may not meet increased demand"

The Department of Health and Social Care (DHSC) published a notification regarding the shortage of Guanfacine 2mg and 3mg modified-release tablets has raised concerns within the healthcare community.


This critical medicine supply notification, issued on March 28th, projects the unavailability of these tablets until the week commencing May 6, 2024.

Guanfacine tablets, commonly prescribed to alleviate symptoms of hyperactivity and impulsivity while enhancing attention and concentration.

However, the scarcity of these specific strengths poses challenges for patients reliant on this medication.

According to a recent survey conducted by Royal Pharmaceutical Society (RPS) and the Pharmacists Defence Association, "more than a third of pharmacists (35%) said they have seen an increase in patients declining prescriptions in the last 12 months."

The organisation further added, "every day pharmacists are asked by patients who are unable to afford all the items their prescription which ones they could 'do without'."

"Patients shouldn’t have to make choices which involve rationing their medicines. No one should face a financial barrier to getting medicines which a health professional has prescribed as necessary."

In 2021/22, revenue from prescription charges and pre-payment certificates in England totaled £651.9 million. According to an NPA survey, commonly foregone medicines due to the prescription charge include antibiotics, painkillers, asthma inhalers, blood pressure medication, and antidepressants.

Nick Kaye, Chair of the National Pharmacy Association, expressed his discontentment with the revision calling it "a shameful neglect of working people on low fixed incomes".

" As pharmacists, we are health care professionals and have no interest in being tax collectors.”

Several countries across the globe experienced shortages of medications for the treatment of attention deficit hyperactivity disorder (ADHD)including the UK, the US and Australia, last year.

Community Pharmacy England (CPE) has cautioned that while alternative strengths of Guanfacine remain accessible, they may not adequately meet the heightened demand, potentially resulting in treatment interruptions for patients.

Pharmacies are advised to endorse prescriptions for unlicensed products appropriately, ensuring compliance with regulatory guidelines.

In response to the shortage, DHSC and NHSE/I have introduced an online Medicines Supply Tool to furnish real-time updates on medication shortages. This digital platform equips healthcare professionals with crucial information to navigate supply challenges effectively.

Furthermore, pharmacies are urged to report any new shortages not listed on the SPS website using the designated shortage reporting tool, facilitating proactive management of emerging supply issues.

Amidst these challenges, the NHS has unveiled a beacon of hope this week with the launch of an ADHD taskforce which seeks to overhaul ADHD care delivery, aligning with the NHS Long Term Plan's overarching objectives for mental health services.

As the healthcare community navigates these supply challenges and embraces innovative solutions, collaborative efforts are paramount to ensuring uninterrupted access to essential medications and delivering optimal care for patients across the UK.

More For You

Pharmacy owners to receive 19p SAF increase in advance payments for April and May 2025

The Single Activity Fee (SAF) was increased by 19p to £1.46 per item, effective from April 2024.

gettyimages

19p SAF increase to be included in April and May 2025 advance payments

Following discussions with the Department of Health and Social Care (DHSC), Community Pharmacy England (CPE) has agreed a mechanism that will allow pharmacy owners to receive the 19p increase to the Single Activity Fee (SAF) earlier for the dispensing months of April and May 2025.

CPE said: “The advance payments for these dispensing months will be adjusted to incorporate the uplift to the SAF. No adjustment to advance payments will be required from the June 2025 dispensing month onwards.”

Keep ReadingShow less
CPE invites pharmacy owners to share their views on new CPCF funding settlement

What do you think should be the next priority for the Government?

gettyimages

Pharmacy owners asked to share their views on new CPCF arrangements

Community Pharmacy England (CPE) is urging pharmacy owners to share their views on the new Community Pharmacy Contractual Framework (CPCF) funding settlement ahead of its next full Committee meeting, scheduled for 30 April–1 May.

The Committee said it had agreed to the settlement "reluctantly," acknowledging that it represents a significant shift after years of real-terms funding cuts, while admitting that it’s “still not sufficient to match the continued scale of pressures facing pharmacy businesses.”

Keep ReadingShow less
Homecare medicines services face many challenges beyond pharmacy's control

Homecare medicines services face many challenges beyond pharmacy's control

gettyimages

GPhC calls for industry-wide collaboration to strengthen homecare medicines services

The General Pharmaceutical Council (GPhC) has called for industry-wide collaboration to improve homecare medicines services to ensure patients always receive their medicines when needed.

The call follows a recent review by the regulator, which identified several challenges facing homecare services, many of which were beyond the immediate control of the pharmacies providing them.

Keep ReadingShow less
Lack of funding deters NI pharmacy contractors from expanding portfolio

W G Hamilton Pharmacy is the third pharmacy in Northern Ireland to be recently sold to first-time buyers.

Pharmacy ownership trends shift in Northern Ireland due to funding gap

An increasing number of pharmacies in Northern Ireland are being acquired by first-time buyers, as existing contractors and groups pull back from expanding their portfolios amid ongoing funding pressures, according to specialist business property adviser Christie & Co.

Among the most recent sales is W G Hamilton Pharmacy, a busy community pharmacy in Ballysillan, North Belfast.

Keep ReadingShow less
RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less